Opiantâs nasal drug spray for opioid overdose gets FDA green light
HQ Team May 23, 2023: The FDA cleared Opiant Pharmaceuticalsâ nasal spray to treat opioid overdose in adult and paediatric patients under the.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team May 23, 2023: The FDA cleared Opiant Pharmaceuticalsâ nasal spray to treat opioid overdose in adult and paediatric patients under the.
HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,.